首页 > SCI期刊 > 医学期刊 > 中科院4区 > SCIE期刊 > Current Pharmaceutical Biotechnology(非官网)

同大类学科其它级别期刊：

中科院 1区期刊 JCR Q1 期刊中科院 2区期刊 JCR Q2 期刊中科院 3区期刊 JCR Q3 期刊中科院 4区期刊 JCR Q4 期刊

Current Pharmaceutical Biotechnology SCIE

国际简称：CURR PHARM BIOTECHNO 参考译名：当前的制药生物技术

主要研究方向：医学-生化与分子生物学非预警期刊审稿周期：一般,3-6周

《当前的制药生物技术》(Current Pharmaceutical Biotechnology)是一本由Bentham Science Publishers B.V.出版的以医学-生化与分子生物学为研究特色的国际期刊，发表该领域相关的原创研究文章、评论文章和综述文章，及时报道该领域相关理论、实践和应用学科的最新发现，旨在促进该学科领域科学信息的快速交流。该期刊是一本未开放期刊，近三年没有被列入预警名单。

4区中科院分区
Q3 JCR分区
139 年发文量
2.2 IF影响因子
未开放 是否OA
73 H-index
2000 创刊年份
Bimonthly 出版周期
English 出版语言

Current Pharmaceutical Biotechnology aims to cover all the latest and outstanding developments in Pharmaceutical Biotechnology. Each issue of the journal includes timely in-depth reviews, original research articles and letters written by leaders in the field, covering a range of current topics in scientific areas of Pharmaceutical Biotechnology. Invited and unsolicited review articles are welcome. The journal encourages contributions describing research at the interface of drug discovery and pharmacological applications, involving in vitro investigations and pre-clinical or clinical studies. Scientific areas within the scope of the journal include pharmaceutical chemistry, biochemistry and genetics, molecular and cellular biology, and polymer and materials sciences as they relate to pharmaceutical science and biotechnology. In addition, the journal also considers comprehensive studies and research advances pertaining food chemistry with pharmaceutical implication. Areas of interest include:

DNA/protein engineering and processing

Synthetic biotechnology

Omics (genomics, proteomics, metabolomics and systems biology)

Therapeutic biotechnology (gene therapy, peptide inhibitors, enzymes)

Drug delivery and targeting

Nanobiotechnology

Molecular pharmaceutics and molecular pharmacology

Analytical biotechnology (biosensing, advanced technology for detection of bioanalytes)

Pharmacokinetics and pharmacodynamics

Applied Microbiology

Bioinformatics (computational biopharmaceutics and modeling)

Environmental biotechnology

Regenerative medicine (stem cells, tissue engineering and biomaterials)

Translational immunology (cell therapies, antibody engineering, xenotransplantation)

Industrial bioprocesses for drug production and development

Biosafety

Biotech ethics

Special Issues devoted to crucial topics, providing the latest comprehensive information on cutting-edge areas of research and technological advances, are welcome.

Current Pharmaceutical Biotechnology is an essential journal for academic, clinical, government and pharmaceutical scientists who wish to be kept informed and up-to-date with the latest and most important developments.

[ 查看全部 ]

投稿咨询加急咨询

Current Pharmaceutical Biotechnology期刊信息

ISSN：1389-2010
出版语言：English
是否OA：未开放
E-ISSN：1873-4316
出版地区：UNITED STATES
是否预警：否
出版商：Bentham Science Publishers B.V.
出版周期：Bimonthly
创刊时间：2000
开源占比：0.0043
Gold OA文章占比：0.66%
OA被引用占比：0
出版国人文章占比：0.12
出版撤稿占比：0
研究类文章占比：38.13%

Current Pharmaceutical Biotechnology CiteScore评价数据（2024年最新版）

CiteScore

SJR

SNIP

CiteScore 指数

5.6

0.492

0.547

学科类别	分区	排名	百分位
大类：Pharmacology, Toxicology and Pharmaceutics 小类：Pharmaceutical Science	Q2	62 / 183	66%
大类：Pharmacology, Toxicology and Pharmaceutics 小类：Biotechnology	Q2	128 / 311	59%

名词解释：CiteScore 是衡量期刊所发表文献的平均受引用次数，是在 Scopus 中衡量期刊影响力的另一个指标。当年CiteScore 的计算依据是期刊最近4年（含计算年度）的被引次数除以该期刊近四年发表的文献数。例如，2022年的 CiteScore 计算方法为：2022年的 CiteScore =2019-2022年收到的对2019-2022年发表的文件的引用数量÷2019-2022年发布的文献数量注：文献类型包括：文章、评论、会议论文、书籍章节和数据论文。

Current Pharmaceutical Biotechnology中科院评价数据

中科院 2023年12月升级版

Top期刊	综述期刊	大类学科		小类学科
否	否	医学	4区	BIOCHEMISTRY & MOLECULAR BIOLOGY 生化与分子生物学 PHARMACOLOGY & PHARMACY 药学	4区 4区

中科院 2022年12月升级版

Top期刊	综述期刊	大类学科		小类学科
否	否	医学	4区	BIOCHEMISTRY & MOLECULAR BIOLOGY 生化与分子生物学 PHARMACOLOGY & PHARMACY 药学	4区 4区

中科院 2021年12月旧的升级版

Top期刊	综述期刊	大类学科		小类学科
否	否	医学	4区	BIOCHEMISTRY & MOLECULAR BIOLOGY 生化与分子生物学 PHARMACOLOGY & PHARMACY 药学	4区 4区

中科院 2021年12月基础版

Top期刊	综述期刊	大类学科		小类学科
否	否	医学	4区	BIOCHEMISTRY & MOLECULAR BIOLOGY 生化与分子生物学 PHARMACOLOGY & PHARMACY 药学	4区 4区

中科院 2021年12月升级版

Top期刊	综述期刊	大类学科		小类学科
否	否	医学	4区	BIOCHEMISTRY & MOLECULAR BIOLOGY 生化与分子生物学 PHARMACOLOGY & PHARMACY 药学	4区 4区

中科院 2020年12月旧的升级版

Top期刊	综述期刊	大类学科		小类学科
否	否	医学	4区	BIOCHEMISTRY & MOLECULAR BIOLOGY 生化与分子生物学 PHARMACOLOGY & PHARMACY 药学	4区 4区

Current Pharmaceutical Biotechnology JCR评价数据（2023-2024年最新版）

按JIF指标学科分区	收录子集	分区	排名	百分位
学科：BIOCHEMISTRY & MOLECULAR BIOLOGY	SCIE	Q4	237 / 313	24.4%
学科：PHARMACOLOGY & PHARMACY	SCIE	Q3	204 / 354	42.5%

按JCI指标学科分区	收录子集	分区	排名	百分位
学科：BIOCHEMISTRY & MOLECULAR BIOLOGY	SCIE	Q3	226 / 313	27.96%
学科：PHARMACOLOGY & PHARMACY	SCIE	Q3	232 / 354	34.6%

Current Pharmaceutical Biotechnology历年数据统计

影响因子

中科院分区

Current Pharmaceutical Biotechnology中国学者发文选摘

1、The Role of VEGF Family in Lipid Metabolism
Author: Zhou, Yan; Zhu, Xueping; Wang, Huan; Duan, Chenglin; Cui, Hanming; Shi, Jingjing; Shi, Shuai; Yuan, Guozhen; Hu, Yuanhui

Journal: CURRENT PHARMACEUTICAL BIOTECHNOLOGY. 2023; Vol. 24, Issue 2, pp. 253-265. DOI: 10.2174/1389201023666220506105026
2、Distribution of Nicotinamide Mononucleotide after Intravenous Injection in Normal and Ischemic Stroke Mice
Author: Zheng, Si-Li; Wang, Dong-Sheng; Dong, Xin; Guan, Yun-Feng; Qi, Qi; Hu, Wen-Jun; Hong, Chen; Zhang, Chuan; Miao, Chao-Yu

Journal: CURRENT PHARMACEUTICAL BIOTECHNOLOGY. 2023; Vol. 24, Issue 2, pp. 299-309. DOI: 10.2174/1389201023666220518113219
3、Factors and Mechanisms Affecting the Secretion of Recombinant Protein in CHO Cells
Author: Yang, Yong-Xiao; Li, Qin; Li, Wei-Dong; Wang, Tian-Yun; Feng, Hui-Gen

Journal: CURRENT PHARMACEUTICAL BIOTECHNOLOGY. 2023; Vol. 24, Issue 3, pp. 391-400. DOI: 10.2174/1389201023666220603121316
4、Research Progress in Elucidating the Mechanisms Underlying Resveratrol Action on Lung Cancer
Author: Xin, Rui; Shen, Biao; Huang, Zhong-Yan; Liu, Ji-Bin; Li, Sha; Jiang, Geng-Xi; Zhang, Jie; Cao, Ya-Hong; Zou, Da-Zhi; Li, Wen; Li, Chun-Guang; Ma, Yu-Shui; Fu, Da

Journal: CURRENT PHARMACEUTICAL BIOTECHNOLOGY. 2023; Vol. 24, Issue 3, pp. 427-437. DOI: 10.2174/1389201023666220818085945
5、Production of Recombinant Human Hybrid Ferritin with Heavy Chain and Light Chain in Escherichia coli and its Characterization
Author: Song, Xiaotong; Zheng, Yongxiang; Liu, Yongdong; Meng, Huan; Yu, Rong; Zhang, Chun

Journal: CURRENT PHARMACEUTICAL BIOTECHNOLOGY. 2023; Vol. 24, Issue 2, pp. 341-349. DOI: 10.2174/1389201023666220517225048
6、LTBP1 Gene Expression in the Cerebral Cortex and its Neuroprotective Mechanism in Mice with Postischemic Stroke Epilepsy
Author: Liu, Bo; Wang, Yan; He, Dongruo; Han, Guochao; Wang, Hao; Lin, Yuan; Zhang, Tianyu; Yi, Chao; Li, Hui

Journal: CURRENT PHARMACEUTICAL BIOTECHNOLOGY. 2023; Vol. 24, Issue 2, pp. 317-329. DOI: 10.2174/1389201023666220608091511
7、N-acetyl Cysteine Inhibits Cell Proliferation and Differentiation of LPS-Induced MC3T3-E1 Cells Via Regulating Inflammatory Cytokines
Author: Li, Wangyang; Zhang, Hui; Chen, Junchi; Tan, Yujie; Li, Ailing; Guo, Ling

Journal: CURRENT PHARMACEUTICAL BIOTECHNOLOGY. 2023; Vol. 24, Issue 3, pp. 450-459. DOI: 10.2174/1389201023666220520102001
8、Syringic Acid Suppressed Proliferation, Invasion, and Migration via Inhibition of Matrix Metalloproteinases Expression on Glioblastoma Cells by Promoting Apoptosis
Author: Li, Dan; Luo, Dongdong; Hu, Su; Zhao, Hailin; Peng, Biao

Journal: CURRENT PHARMACEUTICAL BIOTECHNOLOGY. 2023; Vol. 24, Issue 2, pp. 310-316. DOI: 10.2174/1389201023666220513100129